← Back to all signals
RESEARCH PAPER ANALYSIS

Willingness to participate and model preference for integrated medical and elderly care among older patients with cancer in China: a cross sectional study.

AI interpretation is pending for this paper.

Open original publication →
PMID42998154
JournalSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Publication Date2026-11-07
Ingested2026-11-08 10:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: The global confluence of population aging and the growing chronicity of cancer underscores the urgent need for integrated care models worldwide. As home to the world's largest elderly population, China faces a particular challenge: older patients with cancer must navigate a critical gap between specialized cancer treatment and long-term elderly care. Although Integrated Medical and Elderly Care (IMEC) has emerged as a promising solution, the key factors associated with this group's acceptance of and preference for specific IMEC models remain unclear, thereby hindering effective policy development. OBJECTIVE: Informed by the Andersen Behavioral Model of Health Services Use, this study aimed to explore the factors associated with the willingness of older patients with cancer to adopt IMEC and their preferences among four service models (home-based, institution-based, community-based, and internet-based), in order to inform the design of targeted policies for optimizing integrated care delivery. METHODS: A cross-sectional survey was conducted among 924 older patients with cancer (aged ≥ 60 years) in hospitals in Anhui Province, China. Informed by the Andersen Behavioral Model, data were collected via a structured questionnaire covering three categories of factors: predisposing, enabling, and personal need factors. The outcome variables included IMEC participation willingness (categorized as "no," "depends," or "yes") and IMEC model preference (with internet-based IMEC as the reference group). Descriptive analysis, univariable ordered logistic regression, and multivariable stepwise ordered logistic regression were used to identify factors associated with participation willingness. Chi-square tests and multivariable logistic regression were applied to analyze model preference determinants. RESULTS: Among the 924 patients, 389 (42.1%) reported "no" to IMEC participation, 421 (45.6%) reported "depends," and 114 (12.3%) reported "yes." Multivariable ordered logistic regression identified eight independent factors associated with higher cumulative odds of being in a higher willingness category: knowledge of IMEC (heard but unfamiliar: OR = 2.099, p < 0.001; familiar: OR = 3.332, p < 0.001), gait instability (OR = 1.801, p < 0.001), primary cancer site (gynecological cancer: OR = 3.157, p < 0.001; lymphoma: OR = 0.458, p = 0.027), pension as an income source (OR = 1.473, p = 0.033), high social activity (OR = 1.753, p = 0.005), having two children (OR = 1.459, p = 0.012), access to recreation centers (OR = 1.404, p = 0.017), and life satisfaction (highly satisfied: OR = 2.036, p < 0.001). Regarding model preference, home-based IMEC was most preferred (57.5%), followed by institution-based (20.2%), community-based (18.2%), and internet-based (4.1%). Compared with internet-based IMEC, (1) familiarity with IMEC was associated with lower odds of preferring institution-based (OR = 0.282, p = 0.0309), community-based (OR = 0.331, p = 0.0599), and home-based IMEC (OR = 0.272, p = 0.0144); (2) high IMEC affordability (> 280 USD/month) was associated with higher odds of preferring community-based IMEC (OR = 5.373, p = 0.0118); (3) patients with breast cancer had lower odds of preferring community-based IMEC (OR = 0.147, p = 0.0246); and (4) patients with other cancer sites had lower odds of preferring home-based IMEC (OR = 0.193, p = 0.0086) and community-based IMEC (OR = 0.199, p = 0.0195). CONCLUSION: Knowledge of IMEC, health needs, and economic-social support were key factors associated with older cancer patients' willingness to participate in IMEC. Model preference was associated with knowledge of IMEC, affordability, and primary cancer site. Tailoring IMEC services based on these factors may help improve service acceptance and matching, thereby better meeting the holistic medical and care needs of older patients with cancer.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Inverted Meckel's diverticulum in adults: two case reports and a systematic review. BMC gastroenterology 73.9 2 Torsion and infarction of a large pediatric mesenteric inflammatory myofibroblastic tumor: a case report. Journal of medical case reports 47.5 3 Preoperative Chemotherapy and Its Efficacy in Pediatric Wilms Tumor: A Systematic Review of Randomized Controlled Trials. Cureus 84.94 4 Fear of disease progression in primary caregivers of children with malignant solid tumors: a latent profile analysis. BMC psychology 66.9 5 Protracted copy number alteration evolution in Barrett's oesophagus leading to oesophageal cancer. medRxiv : the preprint server for health sciences 56.0 6 Editorial: The expanding spectrum of hemophagocytic lymphohistiocytosis: pathogenic mechanisms and therapeutic implications. Frontiers in immunology 33.09 7 DNA methylation profiling reveals novel rhabdomyosarcoma subsets with distinct histologic, genetic and clinical properties. medRxiv : the preprint server for health sciences 57.5 8 Brain microvascular endothelial cell dysfunction during Plasmodium infection does not result from astrocyte-derived wingless-related integration site (Wnt)7a deficiency. bioRxiv : the preprint server for biology 50.9 9 The role of microRNAs in neuroblastoma cell differentiation and their therapeutic potential: a systematic review. Frontiers in oncology 79.54 10 Temporal clinical trajectories and Day+14 landmark stratification of infection risk after CD19 CAR T-cell therapy. Frontiers in cellular and infection microbiology 71.52 11 Co-creating the EndoWatch - a smart wearable device for the management of hypothalamic dysfunction in pediatric brain tumor survivors: a pilot study. Frontiers in endocrinology 69.4 12 Ginsenoside RK3 suppresses osteosarcoma via PRMT5/GPX4-ferroptosis axis and enhances doxorubicin chemosensitivity. Frontiers in pharmacology 59.5 13 Age-dependent differences in SARS-CoV-2 entry-factor expression and innate immune responses between pediatric and adult liver organoids. Frontiers in public health 52.62 14 Health beliefs and parental responses to human papillomavirus vaccination in the Middle East: a theory-informed narrative synthesis guided by the health belief model. Frontiers in public health 81.12 15 Diagnostic potential of Aldo-keto reductase 1B10 in pediatric hepatic malignancies: a narrative, hypothesis-generating translational review based on adult evidence and future research directions. Frontiers in medicine 60.5 16 Mucormycosis beyond the classic host: a case series and narrative literature review from a tertiary Greek hospital. Frontiers in fungal biology 60.5 17 Incidence and mortality of breast cancer among adolescent and young adult women worldwide in 2022 and projections for 2040: Implications for surgery. Breast (Edinburgh, Scotland) 57.5 18 Dynamic Radiologic Severity Index is associated with antifungal treatment but does not independently predict initiation in pediatric acute lymphoblastic leukemia with post-chemotherapy pneumonia. Translational pediatrics 75.18 19 Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)-like spectrum with a unique NRAS c.182A>G (p.Q61R) variant: a case report. Translational pediatrics 55.2 20 Predictive value of novel inflammatory markers for post-infectious pulmonary embolism in children. Translational pediatrics 61.2 21 Persistent cerebrospinal fluid tumor cells during transient radiographic response in bilateral retinoblastoma with central nervous system involvement: a pediatric case report. Translational pediatrics 57.42 22 Risk-adapted radiotherapy in pediatric neuroblastoma: current evidence, controversies, and future directions-a narrative review. Translational pediatrics 70.44 23 Identification of amino acid metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical drug treatment in osteosarcoma. Translational pediatrics 74.9 24 Hepatic arterial infusion chemotherapy in combination with immune checkpoint inhibitors and targeted therapy for advanced intrahepatic cholangiocarcinoma. Journal of gastrointestinal oncology 77.18 25 Early on-treatment alpha-fetoprotein and des-gamma-carboxy prothrombin responses are associated with outcomes in unresectable hepatocellular carcinoma receiving transarterial chemoembolization, tyrosine kinase inhibitors and programmed cell death protein-1 inhibitors. Journal of gastrointestinal oncology 75.22 26 Nephrogenic adenoma of the bladder: a case report and review of the literature. Translational andrology and urology 53.4 27 Congenital adrenal hyperplasia combined with a huge adrenal myelolipoma of the unilateral adrenal gland in a 51-year-old female: a case report. Translational andrology and urology 54.3 28 Clinicogenomic characterization and targeted therapy efficacy in Chinese patients with NTRK fusion-positive thyroid cancer: a preliminary retrospective cohort study. Translational cancer research 81.02 29 Real-world efficacy and safety of blinatumomab across three clinical settings in pediatric B-cell acute lymphoblastic leukemia: a single-center retrospective cohort study. Translational cancer research 78.4 30 Telangiectatic Osteosarcoma Arising in a Treated Unicameral Bone Cyst of the Proximal Humerus: A Case Report. Journal of orthopaedic case reports 52.3 31 Multimodal Management of an Aggressive Vertebral Hemangioma in a Child with Neurological Deficit: A Case Report with 5-Year Follow-Up. Journal of orthopaedic case reports 57.0 32 Chernobyl Papillary Thyroid Carcinoma Reveals a Complex Interplay between Environmental Exposures and Lead Genetic Variants Predisposing to Thyroid Cancer. Environmental health perspectives 68.7
PATIENT-FRIENDLY SUMMARY

Willingness to participate and model preference for integrated medical and elderly care among older patients with cancer in China: a cross sectional study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic